Angelman syndrome (AS) is caused by the loss of Ube3A, an ubiquitin ligase that commits specific proteins to proteasomal degradation. How this defect causes autism and other pathological phenotypes associated with AS is unknown. Long-term depression (LTD) of excitatory synaptic transmission mediated by type 5 metabotropic glutamate (mGlu5) receptors was enhanced in hippocampal slices of Ube3A mϪ/pϩ mice, which model AS. No changes were found in NMDA-dependent LTD induced by low-frequency stimulation. mGlu5 receptor-dependent LTD in AS mice was sensitive to the protein synthesis inhibitor anisomycin, and relied on the same signaling pathways as in wild-type mice, e.g., the mitogen-activated protein kinase (MAPK) pathway, the phosphatidylinositol-3-kinase (PI3K)/ mammalian target of rapamycine pathway, and protein tyrosine phosphatase. Neither the stimulation of MAPK and PI3K nor the increase in Arc (activity-regulated cytoskeleton-associated protein) levels in response to mGlu5 receptor activation were abnormal in hippocampal slices from AS mice compared with wild-type mice. mGlu5 receptor expression and mGlu1/5 receptor-mediated polyphosphoinositide hydrolysis were also unchanged in the hippocampus of AS mice. In contrast, AS mice showed a reduced expression of the short Homer protein isoform Homer 1a, and an increased coupling of mGlu5 receptors to Homer 1b/c proteins in the hippocampus. These findings support the link between Homer proteins and monogenic autism, and lay the groundwork for the use of mGlu5 receptor antagonists in AS.
Introduction
Long-term depression (LTD) of excitatory synaptic transmission mediated by type 5 metabotropic glutamate (mGlu5) receptors is amplified in the hippocampus of Fmr1 knock-out mice modeling fragile X syndrome (FXS; Huber et al., 2002; , a genetic disorder associated with autism in ϳ30 -35% of affected children . Pathological behavioral phenotypes of Fmr1 knock-out mice are corrected by germline manipulations that reduce the expression of mGlu5 receptors (Dölen et al., 2007) or by treatments with negative allosteric modulators (NAMs) of mGlu5 receptors (Bhakar et al., 2012; Michalon et al., 2012) , suggesting that exaggerated mGlu5 receptor activity contributes to the pathophysiology of FXS. Moving from these findings, clinical studies are underway to test the effectiveness of mGlu5 receptor NAMs in the treatment of FXS (for review, see Krueger and Bear, 2011; Hagerman et al., 2012) .
Aberrant protein synthesis lies at the core of synaptic modifications associated with FXS (Feng et al., 1995) , and mGlu5 receptor-dependent LTD in the hippocampus relies on dendritic protein synthesis ; but see also Moult et al., 2008; Waung and Huber, 2009) . Because an aberrant protein synthesis is a common motif of autism spectrum disorders , there is increasing interest in examining mGlu5 receptor activity in other models of monogenic autism. Auerbach et al. (2011) found that mice carrying heterozygous loss-of-function mutations of the tuberous sclerosis complex-2 (Tsc2) showed a reduced mGlu5 receptor-dependent LTD in the hippocampus. Some of the phenotypes of Tsc2 ϩ/Ϫ mice were corrected by cross-breeding with Fmr1 knock-out mice or by treatment with a positive allosteric modulator of mGlu5 receptors. Thus, deviations in either direction in mGlu5 receptor-mediated protein synthesis and synaptic plasticity can lead to shared pathological phenotypes (Auerbach et al., 2011) .
Here, we examined mGlu5 receptor-dependent synaptic plasticity in a mouse model of Angelman syndrome (AS), a disorder characterized by developmental delay, epilepsy, hyperactivity, and autistic features (Steffenburg et al., 1996; Williams, 2005) . AS is caused by mutations or deletions of the maternally inherited Ube3A gene, because the paternal allele of Ube3A is epigenetically silenced in neurons (Kishino et al., 1997) . A mouse model of AS has been generated by knocking out 3 kb of the sequence orthologous to exon 2 of the human Ube3A gene (Jiang et al., 1998) . Ube3A is an E3 ubiquitin ligase, which provides substrate specificity to the ubiquitin proteasome system (UPS). The UPS plays a critical role in the regulation of synaptic plasticity (Ehlers, 2003; Dong et al., 2008) , and Ube3A knock-out mice display impaired hippocampal longterm potentiation (Jiang et al., 1998 , Weeber et al., 2003 and visual cortex plasticity (Yashiro et al., 2009; Sato and Stryker, 2010) . Here, we report that AS mice show a selective amplification of mGlu5 receptormediated LTD in the hippocampus and alterations in mGlu5 receptor coupling to Homer proteins.
Materials and Methods

Drugs. (RS)-
, UBE1-41, and anysomicin were obtained from Tocris Cookson. Phenylarsine oxide (PAO) and rapamycin were obtained from Sigma-Aldrich.
Animals. Heterozygous Ube3A mice were purchased from The Jackson Laboratory (Jackson code: 129-Ube3atm1Alb/J) and maintained in a C57BL/6 background. The genotyping was carried by PCR analysis using the following primers: 5Ј-GCTCAAGGTTGTATGCCTTG-GTGCT-3Ј (oIMR1965); 5Ј-AGTTCTCAA GGTAAGCTGAGCTTGC-3Ј (oIMR1966); and 5Ј-TGCATCGCATTGTCTGAGTAGGT-GTC-3Ј (oIMR1967; The Jackson Laboratory).
Mice were kept under environmentally controlled conditions (ambient temperature, 22°C; humidity, 40%) on a 12 h light/dark cycle with food and water ad libitum. All experiments were performed on mice of either sex. Experiments were performed following the Guidelines for Animal Care and Use of the National Institutes of Health. All efforts were made to minimize animal suffering and to reduce the number of animals used.
Electrophysiology. Hippocampal slices were prepared from 4-week-old to 5-week-old Ube3A maternal deficient mice (Ube3A mϪ/pϩ "AS" mice) and their wild-type (Ube3A mϩ/pϩ ) littermates, as previously described (Nisticò et al., 2013) . Brains were rapidly dissected out and parasagittal slices (400 m) were prepared and incubated in artificial CSF (ACSF) containing the following (in mM): 124 NaCl, 3.0 KCl, 1.0 MgCl 2 , 2.0 CaCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 10 glucose, saturated with 95% O 2 , 5% CO 2 , pH 7.4. The CA3 region was not removed from the slices. Slices were allowed to recover for 2-4 h and then placed on a nylon mesh, completely submerged in a small chamber (0.8 ml), and superfused with oxygenated ACSF (30 -31°C) at a constant flow rate of 2.5-3.0 ml/min. The slope of the field EPSPs (fEPSPs) was recorded from the apical dendrite layer of the CA1 pyramidal cells by means of saline-filled glass electrodes of ϳ2-4 M⍀ resistance. Stimulating monopolar electrodes were placed in Schaffer collateral/commissural afferents, and stimulation amplitude was adjusted so as to produce onehalf of the maximal response. Signals were filtered at 3 kHz and digitized at 10 kHz. After the stabilization of the fEPSP, LTD was induced by low-frequency stimulation (1 Hz for 15 min) or following DHPG application (100 M, 5 min). In some experiments DHPG was applied in the presence of the NMDA receptor antagonist D-AP5 (50 M), the proteasome inhibitor UBE1-41 (50 M), the protein tyrosine phosphatase inhibitor PAO (15 M), the mammalian target of rapamycine (mTOR) inhibitor rapamycin (20 M), the extracellular regulated kinase1/2 (ERK1/2) kinase inhibitor UO126 (20 M), or the protein synthesis inhibitor anisomycin (20 M). D-AP5 was applied 20 min before DHPG and maintained during the recording session; UBE1-41 (50 M, from a mother solution of 50 mM in dimethyl sulfoxide) was applied to the slices during the recovery time for 60 min before placement in the recording chamber (Citri et al., 2009) . All the other drugs were applied as indicated (see figures).
Immunoblotting. Slices prepared as described for electrophysiological studies were allowed to recover for Ն3 h. Slices were then incubated with DHPG (100 M) for 5 min and then snap frozen in liquid nitrogen. Samples were homogenized at 4°C in a lysis buffer composed of Tris-HCl 10 mM, pH 7.4; NaCl, 150 mM; EDTA, 5 mM; Igepal 1%; protease (Santa Cruz Biotechnology) and phosphatase (Sigma-Aldrich) inhibitor mixture. Five microliters of tissue extracts were used for protein determination. Proteins (30 g) were resuspended in SDS-bromophenol blue reducing buffer with 40 mM DTT and used for protein analysis. Immunoblotting was performed with the following primary antibodies: Ube3A (Bethyl Laboratories), mGlu5 receptor (Millipore Biotechnology), p-ERK1/2 (Thr202/Tyr204; Santa Cruz Biotechnology), ERK (Cell Signaling Technology), p-Akt (Ser473; Cell Signaling Technology), Akt (Cell Signaling Technology), and Arc (activity-regulated cytoskeletonassociated protein; kindly provided by Prof. P. Worley, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD). After incubation in primary antibody overnight at 4°C, immunoblots were incubated with HRP-conjugated secondary antibodies (Calbiochem) and developed by ECL (Hybond ECL, GE Healthcare Europe).
Measurement of polyphosphoinositide hydrolysis in hippocampal slices. Group I mGlu receptor-stimulated polyphosphoinositide (PI) hydrolysis was also measured in hippocampal slices obtained from postnatal day (P) 21-P30 Ube3A mϪ/pϩ mice and their wild-type littermates as described previously (Nicoletti et al., 1986) . Briefly, hippocampi were sliced (350 ϫ 350 m) using a McIlwain tissue chopper. Forty microliters of gravity-packed slices were then incubated for 60 min in 250 l of buffer containing 1 Ci of myo-[ 3 H]inositol. Slices were incubated with LiCl (10 mM for 10 min) followed by DHPG (100 M). One hour later, the incubation was stopped by the addition of 900 l of methanol/chloroform (2:1). After further addition of 300 l of chloroform and 600 l of water, samples were centrifuged at low speed to facilitate phase separation, and the upper aqueous phase was loaded into Dowex 1-X-8 columns for the separation and quantification of [ Gene expression analysis by real-time PCR. Total RNA was isolated from hippocampi using TRIzol reagent (Invitrogen) according to the manufacturer's protocol and retrotranscribed into cDNA by using SuperScript III Reverse Transcriptase (Invitrogen). Real-time PCR was performed on the StepOnePlus (Applied Biosystems). PCR was performed by using Power SYBR Green PCR Master Mix Kit (Applied Biosystems) according to the manufacturer's instructions. Thermal cycler conditions were as follows: 10 min at 95°C, 40 cycles of denaturation (45 s at 95°C), and combined annealing/extension (1 min at 60°C). Sequences of primers used were as follows: Homer 1a: forward 5Ј-TCTTCAGTC TCCTTTGACACCA-3Ј and reverse 5Ј-CATGATTGCTGAATTGAAT-GTG-3Ј; pan-Homer 1: forward 5Ј-TGGACTGGGATTCTCCTCTG-3Ј and reverse 5Ј-TGTGTCACATCGGGTGTTCT-3Ј; mGlu5 receptor: forward 5Ј-ACGAAGACCAACCGTATTGC-3Ј and reverse 5Ј-AGACTT CTCGGATGCTTGGA-3Ј; cyclophilin A: forward 5Ј-TCCAAAGACA GCAGAAAACTTTCG-3Ј and reverse 5Ј-TCTTCTTGCTGGTCTTGC CATTCC-3Ј. Concentrations of mRNA were calculated from serially diluted standard curves simultaneously amplified with the samples and normalized versus cyclophilin A mRNA levels.
Coimmunoprecipitation. Hippocampi were homogenized at 4°C in a lysis buffer (as above) and 1 mg of total proteins were resuspended in a coimmunoprecipitation buffer (50 mM Tris, pH 7.4, 120 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA, 1 mM EGTA). Proteins were tumbled overnight at 4°C with 5 g of antibody anti-Homer 1b/c or anti-pan-Homer (Santa Cruz Biotechnology). Protein A agarose bead slurry (GE Healthcare) was added for 2 h, and the beads were then washed with coimmunoprecipitation buffer. Western blotting was performed with antibodies against Homer 1b/c, pan-Homer, and mGlu5 receptor (Millipore Biotechnology). Protein extracts from the cerebral cortex of normal and mGlu5 receptor knock-out mice (stored in our laboratory) were used as positive and negative controls, respectively.
Statistical analysis. Electrophysiological data were normalized to the averaged value of the initial slope of the fEPSP obtained during the 20 min period before the application of the conditioning stimulus or DHPG. Data are expressed as the means Ϯ SEM. Significant differences between groups were determined using two-tailed unpaired Student's t test performed on a 10 min average taken 50 min after DHPG application. Statistical significance was set at p Ͻ 0.05. All experiments and the analysis of data were performed in a blind manner. For all statistical comparisons, the n used was the number of animals rather than number of slices. For biochemical experiments, statistical analysis was performed using two-way ANOVA plus Fisher's PLSD test or the Student's t test.
Results
Enhancement of mGlu5 receptordependent LTD in the hippocampus of AS mice
We measured basal synaptic transmission and activity-dependent synaptic plasticity at the Schaffer collateral-CA1 synapses in hippocampal slices prepared from Ube3A maternal deficient mice (Ube3A mϪ/pϩ AS mice) and wild-type (Ube3A mϩ/pϩ ) littermates. No Ube3A was detected in hippocampal slices of AS mice, as expected (Fig.  1A) . AS mice did not show alterations in basal synaptic transmission ( Fig. 1B; p Ͼ 0.05; Jiang et al., 1998) , and in LTD induced by low-frequency stimulation, which is known to be dependent on NMDA receptor activation (for review, see Manabe, 1997) . Stimulation at 1 Hz for 15 min induced a similar depression of synaptic transmission in slices from wild-type and AS mice (wildtype: 85 Ϯ 9%, n ϭ 7; AS: 82 Ϯ 11%, n ϭ 8, p Ͼ 0.05; Fig. 1C ). In contrast, LTD induced by bath application of DHPG (100 M, 5 min) was amplified in AS mice (wild-type: 81 Ϯ 8%, n ϭ 9; AS: 61 Ϯ 6%, n ϭ 12, p Ͻ 0.05; Fig. 1D ). The amplification was unaltered in the presence of the NMDA receptor antagonist, D-AP5 (50 M; 60 Ϯ 7%, n ϭ 4), excluding any role for endogenous NMDA receptor activation in the DHPG/LTD pheno- type of AS mice. As expected , two consecutive applications of DHPG produced maximal depression of fEPSPs in slices from wild-type mice. In contrast, only one application of DHPG was sufficient to achieve saturated levels of LTD in slices from AS mice, such that maximal depression did not differ between the two genotypes (wild-type: 67 Ϯ 6%, n ϭ 8; AS: 62 Ϯ 5%, n ϭ 8, p Ͼ 0.05; Fig. 1E ). Pairedpulse facilitation (PPF), a presynaptic form of short-term synaptic plasticity (Zucker, 1989) , did not differ between wild-type and AS mice at multiple interpulse intervals ( Fig.  1F ; p Ͼ 0.05). The increase in PPF induced by DHPG was also similar between the two genotypes, indicating no changes in the presynaptic component of group I mGlu-receptor-dependent LTD in AS mice ( Fig. 1F ; p Ͼ 0.05).
We performed pharmacological studies to dissect the relative contribution of mGlu1 and mGlu5 receptors in DHPGinduced LTD in the two genotypes. The mGlu5 receptor NAM MPEP (10 M) abolished DHPG-induced LTD in both genotypes (wild-type: 98 Ϯ 3%, n ϭ 7; AS: 98 Ϯ 4%, n ϭ 8; Fig. 1G ; for data with MPEP in normal mice, see Faas et al., 2002; Hou and Klann, 2004; Volk et al., 2006) . In contrast, DHPGinduced LTD was unaffected by the mGlu1 receptor antagonist LY367385 (3 M) in both wild-type and AS mice (data not shown). Thus, activation of mGlu5 receptors mediated DHPG-induced LTD in both genotypes.
Knowing that both DHPG-induced and NMDA receptordependent LTD are affected by ubiquitination inhibitors (Citri et al., 2009), we induced LTD in slices preincubated for 1 h with the proteasome inhibitor UBE1-41 (50 M). DHPG-induced LTD was amplified by UBE1-41 in slices from wild-type mice during the first 40 min after DHPG ( Fig. 2A) . In contrast, UBE1-41 did not affect DHPG-induced LTD in slices from AS mice (Fig. 2B) , indicating that the action of the proteasome inhibitor was occluded by the lack of Ube3A. We also examined NMDA receptordependent LTD induced by low-frequency stimulation in AS mice, finding no effect of UBE1-41 application (Fig. 2C) .
Examination of the signaling pathways mediating the enhanced mGlu5 receptor-dependent LTD in AS mice
We first examined whether DHPG-induced LTD in wild-type and AS mice under our experimental conditions was sensitive to the protein synthesis inhibitor anysomicin (20 M). This treatment abolished DHPG-induced LTD in both genotypes. (Fig. 3A) .
Multiple intracellular signaling pathways, including the mitogenactivated protein kinase (MAPK) pathway, the phosphatidylinositol-3-kinase (PI3K)/Akt/mTOR pathway, and tyrosine phosphatase (PTP)-dependent pathways, are involved in mGlu5-receptordependent LTD in the hippocampus (for review, see Gladding et al., 2009; Collingridge et al., 2010; Lüscher and Huber, 2010) . We examined the involvement of these three pathways by inducing mGlu5 receptor-dependent LTD in the presence of the PTP inhibitor PAO (15 M), the ERK1/2 kinase inhibitor U0126 (20 M), or the mTOR inhibitor rapamycin (20 nM). Treatment of hippocampal slices with each of these inhibitors had no effect on basal synaptic transmission but fully blocked DHPG-induced LTD in both wild-type and AS mice ( Fig. 3B-D; p Ͼ 0.05) . In addition, all these treatments did not reverse changes in PPF induced by DHPG (data not shown). These data suggest that mGlu5 receptor-dependent LTD has the same molecular requirements in the two genotypes. In addition, DHPG-induced phosphorylation of ERK1/2 and Akt in hippocampal slices did not differ significantly between wild-type and AS mice (Fig. 3 E, F ) . It was still possible that Ube3A-target proteins that are regulated by the MAPK or PI3K/Akt/mTOR pathways in response to mGlu5 receptor activation could be altered in AS mice. We measured the expression of Arc, the product of an early inducible gene that has been implicated in mechanisms of mGlu5 receptor-dependent LTD (Park et al., 2008; Waung et al., 2008) . Basal Arc protein levels did not change in hippocampal slices from AS mice ( Fig. 4 ; Greer et al., 2010) . A 5 min exposure of hippocampal slices to DHPG (100 M) increased Arc protein levels to the same extent in wild-type and AS mice (Fig. 4) .
Enhanced coupling of mGlu5 receptors with the long isoforms of Homer proteins in the hippocampus of AS mice
We next examined the possibility that the enhancement of mGlu5 receptor-dependent LTD could rely on mechanisms that lie upstream in the signal propagation. mGlu5 receptor mRNA and protein levels were not altered in the hippocampus of AS mice (Fig. 5 A, B) . We extended the analysis to agonist-stimulated PI hydrolysis, which represents the canonical signal transduction pathway activated by mGlu5 receptors (for review, see Nicoletti et al., 2011). DHPG enhanced [ 3 H]InsP formation to the same extent in hippocampal slices prepared from wild-type and AS mice (Fig. 5C ). Interaction between mGlu5 receptors and Homer proteins Xiao et al., 1998) has been implicated in LTD induction Takayasu et al., 2010; Ronesi et al., 2012) . Interestingly, mRNA and protein levels of the short, activity-induced Homer 1a isoform were reduced in the hippocampus of AS mice, whereas levels of the long, constitutive Homer 1b/c isoforms were unchanged (Fig. 5 D, E) . We also measured mGlu5 receptor protein levels in hippocampal protein immunoprecipitated with either pan-Homer or Homer 1b/c antibodies. mGlu5 receptor levels were significantly increased in pan-Homer immunoprecipitates from AS mice, compared with wild-type mice (Fig. 5F ) . A significant increase in mGlu5 receptor levels was also found in Homer 1b/c immunoprecipitates from AS mice (Fig. 5G) .
Discussion
Drug treatment of AS remains an unmet clinical need, and pharmacological options to control symptoms of the disease have been only partially effective. Ube3A has been implicated in the regulation of activity-dependent synaptic plasticity (Jiang et al., 1998; Weeber et al., 2003) , but its role in mGlu receptor-dependent forms of synaptic plasticity is unexplored. Here, we have shown that mGlu5 receptor-dependent LTD was enhanced in the hippocampus of AS mice, and this was associated with alterations in mGlu5 receptor coupling with Homer proteins. mGlu5 receptordependent LTD was also enhanced by the proteasome inhibitor UBE1-41, as expected (Citri et al., 2009) , and the action of UBE1-41 was occluded in AS mice. Thus, the enhancement of mGlu5 receptordependent LTD in AS mice can be ascribed to the impairment of the ubiquitin/ proteasome system. Changes in mGlu receptor-dependent LTD in the hippocampus of AS mice were specific because LTD induced by low-frequency stimulation (e.g., NMDA receptordependent LTD) was unaltered. This contrasts with the finding of a reduced NMDA receptor-dependent LTD in the visual cortex of AS mice (Yashiro et al., 2009) . We highlight that DHPG-induced LTD under our experimental conditions was insensitive to NMDA receptor blockade, as expected.
LTD mediated by group I mGlu receptors at the Schaffer collateral-CA1 synapses requires dendritic protein synthesis (Waung and Huber, 2009 ). In FXS mice, LTD is enhanced and becomes independent of new protein synthesis because of the lack of FMRP, which normally restrains translation of LTD-related proteins (Huber et al., 2002; Hou et al., 2006; Nosyreva and Huber, 2006) . In apparent contrast with these findings, the mGlu5 receptor-dependent LTD in AS mice was sensitive to the protein synthesis inhibitor anisomycin to the same extent as in control mice. Thus, although the defect of Ube3A is expected to prolong the half-life of postsynaptic proteins, mGlu receptordependent LTD in AS mice retains its sensitivity to de novo protein synthesis.
Arc, which is the product of an immediate early gene, has been directly related to mechanisms of LTD mediated by group I mGlu receptors. Rapid translation of Arc mediates mGlu1/5 receptor-dependent LTD in hippocampal neurons through a persistent increase in the rate of AMPA receptor endocytosis (Waung et al., 2008) . FXS mice show increased Arc levels in dendrites, and lentiviral-mediated expression of FMRP in these mice normalizes both Arc levels and LTD in the hippocampus (Niere et al., 2012) . We expected to find changes in Arc levels in the hippocampus of AS mice because Arc is a substrate for Ube3A (Greer et al., 2010) . In contrast, Arc levels did not differ between wild-type and AS hippocampal slices under the same conditions used for the induction of LTD. However, we cannot exclude the possibility that differences in Arc levels between wild-type and AS mice are present, but anatomically restricted and too small to be revealed by immunoblot analysis.
Recent data suggest that in addition to triggering protein degradation, ubiquitination can modify protein-protein interactions and protein localization and activity (Hicke, 2001; DiAntonio and Hicke, 2004; Chen and Sun, 2009 ). We therefore took steps to find at which level the lack of Ube3A could affect the propagation of mGlu5 receptor signaling. Using specific pharmacological inhibitors, we showed that mGlu5 receptor-dependent LTD in AS mice relied on the same signaling pathways that mediate LTD in wild-type mice, i.e., the PTP, MAPK, and PI3K/ mTOR pathways (Gladding et al., 2009; Collingridge et al., 2010; Lüscher and Huber, 2010) . Stimulation of at least the MAPK and PI3K pathways by DHPG was unaltered in AS mice, suggesting that changes in the activity of these pathways are not responsible for the enhanced mGlu5 receptor-dependent LTD. mGlu5 receptor expression and mGlu5 receptor-mediated PI hydrolysis were also unaltered in AS mice.
AS mice differed from wild-type mice in the coupling mechanism of mGlu5 receptors to Homer proteins. Long, constitutive isoforms of Homer proteins (Homer 1b, 1c, 2, and 3) multimerize through their C-terminal coiled-coil domains and target mGlu1a and mGlu5 receptors to the postsynaptic density through interactions with SHANK (SH3 and multiple ankyrin repeat domains protein). In addition, long isoforms of Homer link mGlu1a and mGlu5 receptors to signaling molecules, such as PIKE (phosphoinositide-3 kinase enhancer), EF2K (the elongation factor 2 kinase), the inositol-1,4,5-trisphosphate receptors TRPC1 and TRPC3, N-type calcium channels, and M-type potassium channels (Brakeman et al., 1997; Tu et al., , 1999 Xiao et al., 1998; Kammermeier et al., 2000; . In contrast, Homer 1a, a short and activity-inducible form of Homer lacking the coiled-coil domain, acts as a dominant negative isoform by uncoupling mGlu1a or mGlu5 receptors from postsynaptic effectors (Kammermeier and Worley, 2007) .
Recent evidence links Homer proteins to mGlu5 receptormediated synaptic plasticity and autism. Disruption of mGlu5 interaction with Homer proteins blocks mGlu5 receptordependent LTD and protein synthesis in normal mice (Ronesi et al., 2012) . In FXS mice, mGlu5 receptors are less associated with the long Homer isoforms and more associated with Homer 1a (Giuffrida et al., 2005; Ronesi et al., 2012) . Genetic deletion of Homer 1a corrects several phenotypes in FXS mice, but not the enhancement of mGlu5 receptor-dependent LTD in the hippocampus (Ronesi et al., 2012) . The gene encoding for Homer 1 has been identified as a novel risk gene for nonsyndromic autism. Rare Homer 1 gene variants that potentially affect protein function cosegregate closely with autism among children of affected families (Kelleher et al., 2012) .
In AS mice, changes in the coupling of mGlu5 receptors to Homer proteins were opposite to those seen in FXS mice. AS mice showed reduced Homer 1a mRNA and protein levels, and increased association of mGlu5 receptors with Homer proteins in immunoprecipitates. The reduction of Homer 1a in AS mice was unexpected because Homer 1a is a substrate for ubiquitination, and proteasome inhibitors are known to enhance Homer 1a levels (Ageta et al., 2001) . Perhaps the lack of Ube3A enhances the stability of a negative regulator of Homer 1a, which may function at transcriptional or translational levels. Alternatively, in AS mice the Homer 1a phenotype may lay upstream of the proteasome system, which may help to explain why Homer 1a levels are not enhanced despite the lack of Ube3A. It will be interesting to examine whether an enhanced coupling of mGlu5 receptors to long Homer isoforms has any influence on the efficiency of the ubiquitine/proteasomal system. Whatever the mechanism, the reduction of Homer 1a suggests that mGlu5 receptors are more efficiently coupled to postsynaptic effectors in AS mice. This fits nicely with the enhanced mGlu5 receptor-dependent LTD found in AS mice, although the precise mechanism that is ultimately responsible for the amplification of LTD is unknown. It is intriguing that in FXS and AS mice opposite changes in mGlu5/Homer coupling are associated with an enhanced mGlu5 receptordependent LTD. One should take into account the fact that a reduced association of mGlu5 receptors to long Homer isoforms restrains receptor coupling to postsynaptic effectors on one side (Kammermeier and Worley, 2007) , but enhances the agonist-independent "constitutive" activity of mGlu5 receptors on the other side (Ango et al., 2001) . Whether changes in the constitutive activity of mGlu5 receptors have any role in the pathological phenotype of AS mice is unknown.
In conclusion, we have described for the first time the association of AS with abnormalities in the interaction between mGlu5 receptors and Homer proteins, and an enhancement of mGlu5 receptor-dependent LTD in the hippocampus. These findings lay the groundwork for the use of mGlu5 receptor antagonists in models of AS.
